Dachaigh › Luchd-obrach › B. Riley Securities, Inc.
B. Riley Securities, Inc.: Tuarastalan H-1B agus taic bhìosa
Chuir B. Riley Securities, Inc. 11 iarrtasan cumha-obrach a-steach airson bhìosaichean H-1B agus bhìosaichean co-cheangailte ann am bliadhnaichean ionmhais 2023–2026; le teisteanas: 10. Tuarastal meadhanach a chaidh a thabhann: $160,000.
A bheil B. Riley Securities, Inc. a’ toirt taic do bhìosaichean H-1B?
Chuir B. Riley Securities, Inc. 11 iarrtasan cumha-obrach a-steach ann am bliadhnaichean ionmhais 2023–2026, an tè as ùire air a chur a-steach air 21 Cèit 2026. Is e LCA a’ chiad cheum ann an iarrtas H-1B, mar sin tha an neach-fastaidh air taic a thoirt do luchd-obrach H-1B no air ullachadh airson sin a dhèanamh; cha gharantaich e taic airson dreuchd shònraichte sam bith. Thoir sùil air liostaichean obrach an neach-fastaidh fhèin.
Tuarastalan a rèir tiotal obrach
| Tiotal dreuchd | LCAs | Tuarastal meadhanach |
|---|---|---|
| Associate | 2 | $160,000 |
| Research Analyst - Healthcare (Biotech) | 1 | $140,000 |
| Analyst, Investment Banking | 1 | $95,000 |
| Managing Director, Group Head of Healthcare Research | 1 | $250,000 |
| Managing Director, Group Head of Healthcare | 1 | — |
| Research Associate | 1 | $85,000 |
| Sr. Research Associate | 1 | $95,000 |
| Associate Analyst, Investment Banking | 1 | $160,000 |
| Associate, Investment Banking | 1 | $160,000 |
| Managing Director, Research - Healthcare/Biotech Sector | 1 | $260,000 |
Iarrtasan a rèir bliadhna ionmhais
| Bliadhna mhaoine | LCAs | Tuarastal meadhanach |
|---|---|---|
| FY2023 | 5 | $150,000 |
| FY2025 | 2 | $127,500 |
| FY2026 | 4 | $160,000 |
Ìrean tuarastail làithreach
Suidhichidh Roinn an Obrach ceithir ìrean tuarastail làithreach airson gach dreuchd agus sgìre, bho Ìre I (inntrigeadh) gu Ìre IV (gu tur comasach). Taghaidh an neach-fastaidh an ìre a fhreagras ri riatanasan na h-obrach.
Far a bheil na h-obraichean
Dreuchdan
Iarrtasan as ùire
| Tiotal dreuchd | Tuarastal bunasach | Àite | Air a chur a-steach | Ceann-latha tòiseachaidh | Inbhe |
|---|---|---|---|---|---|
| Managing Director, Research - Healthcare/Biotech Sector | $260,000 Ìre IV | Arlington, VA | 21 Cèit 2026 | 1 Dàmh 2026 | Dearbhaichte |
| Associate, Investment Banking | $160,000 Ìre II | New York, NY | 8 Cèit 2026 | 1 Dàmh 2026 | Dearbhaichte |
| Associate Analyst, Investment Banking | $160,000 Ìre II | New York, NY | 30 Gibl 2026 | 1 Dàmh 2026 | Dearbhaichte, an uair sin air a tharraing air ais |
| Sr. Research Associate | $95,000 Ìre I | Arlington, VA | 7 Cèit 2025 | 1 Dàmh 2025 | Dearbhaichte |
| Research Associate | $85,000 Ìre I | Arlington, VA | 1 Dàmh 2024 | 7 Dàmh 2024 | Dearbhaichte, an uair sin air a tharraing air ais |
| Associate | $160,000 H-1B1 (Singapore) · Ìre II | New York, NY | 9 Cèit 2024 | 10 Lùna 2024 | Dearbhaichte, an uair sin air a tharraing air ais |
| Managing Director, Group Head of Healthcare Research | $250,000 Ìre III | Greenbrae, CA | 28 Lùna 2023 | 13 Gearr 2024 | Dearbhaichte |
| Managing Director, Group Head of Healthcare | $250,000 Ìre IV | Greenbrae, CA | 23 Lùna 2023 | 13 Gearr 2024 | Air a tharraing air ais |
| Research Analyst - Healthcare (Biotech) | $140,000 Ìre II | Arlington, VA | 6 Ògmh 2023 | 1 Dàmh 2023 | Dearbhaichte |
| Associate | $160,000 H-1B1 (Singapore) · Ìre III | New York, NY | 1 Ògmh 2023 | 10 Lùna 2023 | Dearbhaichte |
| Analyst, Investment Banking | $95,000 Ìre I | New York, NY | 16 Cèit 2023 | 1 Dàmh 2023 | Dearbhaichte |
Is e na tuarastalan an ìre as ìsle den tuarastal a chaidh a thabhann air gach iarrtas, air an tionndadh gu suim bhliadhnail; cleachdaidh na staitistigean iarrtasan làn-aimsire le teisteanas a-mhàin. Chan eil LCA na aontachadh bhìosa agus faodaidh aon LCA còmhdach a dhèanamh air iomadh dreuchd. Stòr: Roinn an Obrach na SA, Dàta Foillseachaidh OFLC LCA, bliadhnaichean ionmhais 2023–2026 (co-dhùnadh as ùire 30 Ògmh 2026).